| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 143.54B | 150.26B | 139.87B | 122.67B | 113.05B | 103.74B |
| Gross Profit | 40.60B | 42.18B | 39.59B | 27.14B | 24.09B | 23.20B |
| EBITDA | 12.77B | 10.59B | 11.41B | 9.64B | 9.58B | 9.17B |
| Net Income | 7.34B | 7.12B | 5.83B | 5.68B | 5.66B | 6.18B |
Balance Sheet | ||||||
| Total Assets | 96.57B | 106.99B | 100.80B | 92.64B | 87.89B | 82.14B |
| Cash, Cash Equivalents and Short-Term Investments | 32.05B | 37.43B | 33.54B | 31.39B | 32.45B | 32.86B |
| Total Debt | 6.14B | 5.15B | 6.11B | 1.75B | 1.90B | 2.97B |
| Total Liabilities | 26.27B | 31.12B | 30.76B | 23.49B | 22.41B | 20.49B |
| Stockholders Equity | 66.97B | 74.82B | 66.69B | 68.13B | 64.34B | 60.37B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.54B | -243.00M | 5.02B | 7.01B | 3.47B |
| Operating Cash Flow | 0.00 | 10.10B | 1.70B | 5.47B | 7.76B | 4.46B |
| Investing Cash Flow | 0.00 | -2.55B | 1.80B | -2.92B | -4.68B | -1.84B |
| Financing Cash Flow | 0.00 | -4.28B | -2.04B | -3.34B | -3.55B | -3.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥97.14B | 39.51 | 1.46% | 1.18% | 15.23% | 37.37% | |
71 Outperform | ¥43.68B | 12.75 | ― | 2.93% | 18.22% | 35.76% | |
70 Outperform | ¥102.95B | 14.05 | ― | 1.93% | 7.43% | 24.43% | |
66 Neutral | ¥99.16B | 21.37 | ― | 2.19% | 3.42% | 7.82% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
61 Neutral | ¥115.21B | 7.31 | 15.81% | 2.93% | 12.51% | 12.42% | |
57 Neutral | ¥62.38B | 9.29 | ― | 2.89% | 4.32% | 11.25% |